"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Tanja Obradovic: Improved PFS versus current SOC of taxane, trastuzumab and pertuzumab
Yan Leyfman: Honored to participate in the Legorreta Cancer Center's Symposium on Tumor Plasticity in Diagnosis and Treatment.
Kinjal Shankar Majumdar: Our reflections to ASCO IDEA
NIVOPOSTOP Phase 3 Trial: Adding Nivolumab to Standard Chemoradiotherapy Improves Disease-Free Survival in High-Risk Resected LA-SCCHN
ESMO4Carers: Exchanging best practices on maintaining professional wellbeing and preventing burnout
Marcio Covas Moschovas: S-RARP is a safe and feasible treatment option for patients with recurrent prostate cancer
